Humans carrying p16 mutations have not only increased susceptibility to melanoma, but usually also numerous melanocytic naevi (moles), often large (Gruis et al, 1995; Bennett and Medrano, 2002; Bennett, 2003), implying a role for p16 in limiting naevus growth in these families. The gene discussed is CDKN2A; the disease is melanocytic nevus.